| Quarter | Filling ID |
|---|---|
| Q4 25 | 0002002654-26-000001 |
| Q3 25 | 0002002654-25-000006 |
| Q2 25 | 0002002654-25-000004 |
| Q1 25 | 0002002654-25-000003 |
| Q4 24 | 0002002654-25-000001 |
| Q3 24 | 0002002654-24-000005 |
| Q2 24 | 0002002654-24-000004 |
| Q1 24 | 0002002654-24-000002 |
| Q4 23 | 0002002654-24-000001 |
| Q3 23 | 0002002654-23-000008 |
| Q2 23 | 0002002654-23-000007 |
| Q1 23 | 0002002654-23-000006 |
| Q4 22 | 0002002654-23-000005 |
| Q3 22 | 0002002654-23-000004 |
| Q2 22 | 0002002654-23-000003 |
| Q1 22 | 0002002654-23-000002 |
| Q4 21 | 0002002654-23-000001 |
| Name | Title | CUSIP | Ticker | Value | Shares | Share Price | Investment | % of Portfolio |
|---|---|---|---|---|---|---|---|---|
| Seagen Inc. | COM | 81181C104 | $8,300,656 | 46,912,266 | SOLE | |||
| Incyte Corporation | COM | 45337C102 | $2,746,628 | 36,154,117 | SOLE | |||
| BeiGene, Ltd. | SPONSORED ADR | 07725L102 | $1,888,611 | 11,668,897 | SOLE | |||
| BioMarin Pharmaceutical Inc. | COM | 09061G101 | $631,510 | 7,620,494 | SOLE | |||
| ACADIA Pharmaceuticals Inc. | COM | 4225108 | $590,702 | 41,923,486 | SOLE | |||
| Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | $451,103 | 4,852,655 | SOLE | |||
| argenx SE | SPONSORED ADR | 04016X101 | $424,178 | 1,119,557 | SOLE | |||
| BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | $134,480 | 12,710,818 | SOLE | |||
| Kodiak Sciences Inc. | COM | 50015M109 | $132,252 | 17,310,490 | SOLE | |||
| Global Blood Therapeutics, Inc. | COM | 37890U108 | $119,253 | 3,732,502 | SOLE | |||
| AbCellera Biologics Inc. | COM | 00288U106 | $111,294 | 10,450,180 | SOLE | |||
| Madrigal Pharmaceuticals, Inc. | COM | 558868105 | $107,314 | 1,499,213 | SOLE | |||
| Mirati Therapeutics, Inc. | COM | 60468T105 | $94,639 | 1,409,784 | SOLE | |||
| Immunocore Holdings plc | ADS | 45258D105 | $94,048 | 2,520,730 | SOLE | |||
| Horizon Therapeutics Public Ltd Co | SHS | G46188101 | $91,605 | 1,148,504 | SOLE | |||
| Cerus Corporation | COM | 157085101 | $84,997 | 16,067,558 | SOLE | |||
| Travere Therapeutics, Inc. | COM | 89422G107 | $79,959 | 3,300,009 | SOLE | |||
| Replimune Group, Inc. | COM | 76029N106 | $62,772 | 3,591,081 | SOLE | |||
| Entrada Therapeutics, Inc. | COM | 29384C108 | $59,266 | 4,865,819 | SOLE | |||
| IGM Biosciences, Inc. | COM | 449585108 | $56,905 | 3,156,102 | SOLE | |||
| Kymera Therapeutics, Inc. | COM | 501575104 | $56,704 | 2,879,825 | SOLE | |||
| Krystal Biotech, Inc. | COM | 501147102 | $53,036 | 807,735 | SOLE | |||
| Prelude Therapeutics Inc. | COM | 74065P101 | $52,846 | 10,123,824 | SOLE | |||
| Nurix Therapeutics, Inc. | COM | 67080M103 | $49,187 | 3,882,125 | SOLE | |||
| Legend Biotech Corporation | SPONSORED ADS | 52490G102 | $47,116 | 856,658 | SOLE | |||
| Alkermes plc | SHS | G01767105 | $44,685 | 1,500,000 | SOLE | |||
| ChemoCentryx, Inc. | COM | 16383L106 | $44,422 | 1,792,657 | SOLE | |||
| Chinook Therapeutics, Inc. | COM | 16961L106 | $44,321 | 2,534,102 | SOLE | |||
| Insmed Incorporated | COM PAR $.01 | 457669307 | $42,516 | 2,156,001 | SOLE | |||
| Immatics N.V. | SHS | N44445109 | $38,531 | 4,423,731 | SOLE | |||
| DBV Technologies S.A. | SPONSORED ADR | 23306J101 | $37,266 | 14,614,264 | SOLE | |||
| Sarepta Therapeutics, Inc. | DBCV 1.5% 11/15/2024 | 803607AB6 | $36,577 | 29,174,000 | SOLE | |||
| Insmed Incorporated | Note 0.75% 6/1/2028 | 457669AB5 | $33,278 | 40,000,000 | SOLE | |||
| Aerovate Therapeutics, Inc. | COM | 8064107 | $32,354 | 2,070,010 | SOLE | |||
| Amarin Corporation plc | SPONSORED ADR | 23111206 | $31,543 | 21,169,805 | SOLE | |||
| Verastem, Inc. | COM | 92337C104 | $31,307 | 26,988,898 | SOLE | |||
| Ultragenyx Pharmaceutical Inc. | COM | 90400D108 | $28,098 | 470,974 | SOLE | |||
| 2seventy bio, Inc. | COMMON STOCK | 901384107 | $27,228 | 2,062,744 | SOLE | |||
| Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | $27,128 | 2,799,577 | SOLE | |||
| Biomea Fusion, Inc. | COM | 09077A106 | $25,213 | 2,104,559 | SOLE | |||
| Altimmune, Inc. | COM | 02155H200 | $24,282 | 2,075,403 | SOLE | |||
| Invitae Corporation | COM | 46185L103 | $24,091 | 9,873,488 | SOLE | |||
| Pacific Biosciences of California, Inc. | COM | 69404D108 | $24,067 | 5,444,963 | SOLE | |||
| Xenon Pharmaceuticals Inc. | COM | 98420N105 | $22,865 | 751,639 | SOLE | |||
| Heron Therapeutics, Inc. | COM | 427746102 | $22,687 | 8,131,678 | SOLE | |||
| Merus N.V. | COM | N5749R100 | $22,536 | 995,397 | SOLE | |||
| Verve Therapeutics, Inc. | COM | 92539P101 | $21,645 | 1,416,530 | SOLE | |||
| Design Therapeutics, Inc. | COM | 25056L103 | $20,113 | 1,436,636 | SOLE | |||
| Affimed N.V. | COM | N01045108 | $18,273 | 6,596,830 | SOLE | |||
| Instil Bio, Inc. | COM | 45783C101 | $17,989 | 3,893,700 | SOLE |